Kenneth Erland Johnson - Net Worth and Insider Trading
Kenneth Erland Johnson Net Worth
The estimated net worth of Kenneth Erland Johnson is at least $18,100 dollars as of 2024-09-20. Kenneth Erland Johnson is the See Remarks of Xeris Biopharma Holdings Inc and owns about 6,115 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $18,100. Details can be seen in Kenneth Erland Johnson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Erland Johnson has not made any transactions after 2020-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Erland Johnson
Kenneth Erland Johnson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Erland Johnson owns 1 companies in total, including Xeris Biopharma Holdings Inc (XERS) .
Click here to see the complete history of Kenneth Erland Johnson’s form 4 insider trades.
Insider Ownership Summary of Kenneth Erland Johnson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2021-10-05 | See Remarks |
Kenneth Erland Johnson Latest Holdings Summary
Kenneth Erland Johnson currently owns a total of 1 stock. Kenneth Erland Johnson owns 6,115 shares of Xeris Biopharma Holdings Inc (XERS) as of February 14, 2020, with a value of $18,100.
Latest Holdings of Kenneth Erland Johnson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2020-02-14 | 6,115 | 2.96 | 18,100 |
Holding Weightings of Kenneth Erland Johnson
Kenneth Erland Johnson Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Erland Johnson has made a total of 1 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 2,410 shares on February 14, 2020, which cost Kenneth Erland Johnson around $10,002.
Insider Trading History of Kenneth Erland Johnson
- 1
Kenneth Erland Johnson Trading Performance
GuruFocus tracks the stock performance after each of Kenneth Erland Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth Erland Johnson is 7.75%. GuruFocus also compares Kenneth Erland Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth Erland Johnson within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth Erland Johnson's insider trading performs compared to the benchmark.
Performance of Kenneth Erland Johnson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.65 | | | | | |
| Relative Return to S&P 500(%) | -9.7 | | | | | |
Kenneth Erland Johnson Ownership Network
Kenneth Erland Johnson Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Kenneth Erland Johnson is the See Remarks of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Kenneth Erland Johnson made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 8,800 shares, with a net purchase of 8,800 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Kenneth Erland Johnson Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Erland Johnson. You might contact Kenneth Erland Johnson via mailing address: C/o Xeris Pharmaceuticals, Inc., 180 N. Lasalle Street, Suite 1800, Chicago Il 60601.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
